NO308304B1 - Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst - Google Patents

Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst

Info

Publication number: NO308304B1
Authority: NO; Norway
Prior art keywords: derivatives; preparation; pharmaceutical compositions; pct; psychosis
Prior art date: 1995-05-26

Application number

NO970327A

Other languages

English (en)

Norwegian (no)

Other versions

NO970327L (no

NO970327D0 (no

Inventor

Rafael Foguet

Lluis Anglada

Aurelio Sacristsn

Josep M Castello

Jose A Ortiz

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-26

Filing date

1997-01-24

Publication date

2000-08-28

1997-01-24 Application filed by Ferrer Int filed Critical Ferrer Int

1997-01-24 Publication of NO970327L publication Critical patent/NO970327L/no

1997-01-24 Publication of NO970327D0 publication Critical patent/NO970327D0/no

2000-08-28 Publication of NO308304B1 publication Critical patent/NO308304B1/no

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 3
208000019901 Anxiety disease Diseases 0.000 title abstract 2
208000028017 Psychotic disease Diseases 0.000 title abstract 2
230000036506 anxiety Effects 0.000 title abstract 2
201000000980 schizophrenia Diseases 0.000 title abstract 2
JLPUISACQXFVRC-UHFFFAOYSA-N 2,5-dihydro-1,3-thiazole Chemical compound C1SCN=C1 JLPUISACQXFVRC-UHFFFAOYSA-N 0.000 title 1
BDTRIDKONHOQQN-UHFFFAOYSA-N 4h-pyrimidin-5-one Chemical class O=C1CN=CN=C1 BDTRIDKONHOQQN-UHFFFAOYSA-N 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 2
UEZROEGYRDHMRV-UHFFFAOYSA-N [1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical class O=C1C=CN=C2SC=CN12 UEZROEGYRDHMRV-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
-1 methylendioxy Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Cephalosporin Compounds (AREA)

NO970327A 1995-05-26 1997-01-24 Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst NO308304B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES09501029A ES2097093B1 (es)	1995-05-26	1995-05-26	Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona.
PCT/EP1996/002254 WO1996037498A1 (en)	1995-05-26	1996-05-24	5H-THIAZOLO[3,2-a]PYRIMIDIN-5-ONE DERIVATIVES

Publications (3)

Publication Number	Publication Date
NO970327L NO970327L (no)	1997-01-24
NO970327D0 NO970327D0 (no)	1997-01-24
NO308304B1 true NO308304B1 (no)	2000-08-28

Family

ID=8290506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970327A NO308304B1 (no)	1995-05-26	1997-01-24	Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst

Country Status (17)

Country	Link
US (1)	US5798361A (de)
EP (1)	EP0773947B1 (de)
JP (1)	JPH10503782A (de)
AT (1)	ATE196633T1 (de)
AU (1)	AU698455B2 (de)
CA (1)	CA2195578A1 (de)
DE (1)	DE69610477T2 (de)
DK (1)	DK0773947T3 (de)
ES (1)	ES2097093B1 (de)
IL (1)	IL118280A (de)
MX (1)	MX9601953A (de)
NO (1)	NO308304B1 (de)
NZ (1)	NZ308533A (de)
PT (1)	PT773947E (de)
TW (1)	TW430666B (de)
WO (1)	WO1996037498A1 (de)
ZA (1)	ZA964091B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4443451A (en) *	1981-07-15	1984-04-17	Janssen Pharmaceutica N.V.	Bicyclic pyrimidin-5-one derivatives
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
NZ254113A (en) *	1992-07-13	1995-08-28	Janssen Pharmaceutica Nv	Fused piperidine derivatives and medicaments

1995
- 1995-05-26 ES ES09501029A patent/ES2097093B1/es not_active Expired - Lifetime
1996
- 1996-05-14 TW TW085105655A patent/TW430666B/zh not_active IP Right Cessation
- 1996-05-15 IL IL11828096A patent/IL118280A/xx not_active IP Right Cessation
- 1996-05-22 ZA ZA964091A patent/ZA964091B/xx unknown
- 1996-05-23 MX MX9601953A patent/MX9601953A/es not_active IP Right Cessation
- 1996-05-24 DK DK96919807T patent/DK0773947T3/da active
- 1996-05-24 AU AU58203/96A patent/AU698455B2/en not_active Ceased
- 1996-05-24 WO PCT/EP1996/002254 patent/WO1996037498A1/en not_active Ceased
- 1996-05-24 NZ NZ308533A patent/NZ308533A/en unknown
- 1996-05-24 US US08/765,935 patent/US5798361A/en not_active Expired - Fee Related
- 1996-05-24 EP EP96919807A patent/EP0773947B1/de not_active Expired - Lifetime
- 1996-05-24 PT PT96919807T patent/PT773947E/pt unknown
- 1996-05-24 DE DE69610477T patent/DE69610477T2/de not_active Expired - Fee Related
- 1996-05-24 JP JP8535401A patent/JPH10503782A/ja active Pending
- 1996-05-24 AT AT96919807T patent/ATE196633T1/de not_active IP Right Cessation
- 1996-05-24 CA CA002195578A patent/CA2195578A1/en not_active Abandoned
1997
- 1997-01-24 NO NO970327A patent/NO308304B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL118280A0 (en)	1996-09-12
ZA964091B (en)	1997-01-21
PT773947E (pt)	2001-01-31
ATE196633T1 (de)	2000-10-15
MX9601953A (es)	1997-08-30
AU5820396A (en)	1996-12-11
WO1996037498A1 (en)	1996-11-28
TW430666B (en)	2001-04-21
ES2097093B1 (es)	1998-01-16
NO970327L (no)	1997-01-24
DE69610477T2 (de)	2001-05-10
IL118280A (en)	1999-10-28
NO970327D0 (no)	1997-01-24
EP0773947B1 (de)	2000-09-27
DK0773947T3 (da)	2000-10-16
DE69610477D1 (de)	2000-11-02
NZ308533A (en)	1997-11-24
CA2195578A1 (en)	1996-11-28
US5798361A (en)	1998-08-25
AU698455B2 (en)	1998-10-29
EP0773947A1 (de)	1997-05-21
ES2097093A1 (es)	1997-03-16
JPH10503782A (ja)	1998-04-07

Legal Events

Date	Code	Title	Description
2002-12-30	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN NOVEMBER 2002

Publication	Publication Date	Title
TW274547B (de)	1996-04-21
HUP0103987A2 (en)	2003-05-28	Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
AU2337097A (en)	1997-10-22	Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
NO962855D0 (no)	1996-07-05	Nye piperidin-derivater med PAF-antagonist-aktivitet
ATE297929T1 (de)	2005-07-15	Azabicycloalkan-derivate zur verwendung als inhibitoren der serotonin-wiederaufnahme und als 5ht2a antagonisten
DK0902018T3 (da)	2008-10-20	2-(arylpheny)amino-imidazolinderivater
NO960441L (no)	1996-02-02	Benzopyraner og farmasöytiske forbindelser inneholdende dem
MXPA04003278A (es)	2004-07-23	Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
MA27068A1 (fr)	2004-12-20	Derives d'alkylaminopyridazinone substitues, leur procede de preparation et composition pharmaceutique les contenant.
ATE168674T1 (de)	1998-08-15	Neue perhydroisoindolderivate und ihre herstellung
NO308001B1 (no)	2000-07-03	Nye kromenforbindelser, deres anvendelse for fremstilling av et preparat samt farmasøytisk sammensetning inneholdende kromenforbindelser
ATE196633T1 (de)	2000-10-15	5h- thiazolo(3,2-a)pyrimidin-5-on-derivate
ATE203022T1 (de)	2001-07-15	4-(6-fluor-1,2-benzisoxazolyl)-1-piperidinyl- propoxy-chromen-4-on-derivate,ihre herstellung und ihre verwendung in der behandlung von psychosen, schizophrenie und angstzuständen
HRP20000027B1 (en)	2006-07-31	Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
ATE96803T1 (de)	1993-11-15	Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
HUP0303691A2 (hu)	2004-03-01	Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására